Cargando…

Correction: Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244181/ http://dx.doi.org/10.1371/journal.pone.0114809

Ejemplares similares

Factors Influencing the Measurement of Lysosomal Enzymes Activity in Human Cerebrospinal Fluid
por: Persichetti, Emanuele, et al.
Publicado: (2014)

Cerebrospinal Fluid Lysosomal Enzymes and Alpha-Synuclein in Parkinson's Disease
por: Parnetti, Lucilla, et al.
Publicado: (2014)

Author Correction: In vivo assessment of cerebrospinal fluid efflux to nasal mucosa in humans
por: Melin, Erik, et al.
Publicado: (2023)

Correction: Neural activity induced by sensory stimulation can drive large-scale cerebrospinal fluid flow during wakefulness in humans
por: Williams, Stephanie D., et al.
Publicado: (2023)

Correction: Increased Interleukin-17 in Peripheral Blood and Cerebrospinal Fluid of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2015)

Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
por: De Kort, Anna M., et al.
Publicado: (2021)

Correction to: A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases
por: Katsigianni, Eleni Ioanna, et al.
Publicado: (2022)

Correction: Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of Rodents
por: Lahmann, Carolina, et al.
Publicado: (2019)

Correction to: Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
por: Lee, Bongyong, et al.
Publicado: (2022)

Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
por: Visser, Pieter Jelle, et al.
Publicado: (2022)

Correction to “Neurofilament light chain levels in cerebrospinal fluid as a sensitive biomarker for cerebral adrenoleukodystrophy”
Publicado: (2023)

Correction: A Proteomic Analysis of Individual and Gender Variations in Normal Human Urine and Cerebrospinal Fluid Using iTRAQ Quantification
por: Guo, Zhengguang, et al.
Publicado: (2019)

Correction to: A26 Cerebrospinal fluid outflow resistance is increased following small-moderate ischaemic stroke
por: Patabendige, Adjanie, et al.
Publicado: (2019)

Correction to: Adiponectin in Cerebrospinal Fluid from Patients Affected by Multiple Sclerosis Is Correlated with the Progression and Severity of Disease
por: Signoriello, Elisabetta, et al.
Publicado: (2021)

Correction: Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
por: Zhitomirsky, Benny, et al.
Publicado: (2022)

Distinct Lysosomal Network Protein Profiles in Parkinsonian Syndrome Cerebrospinal Fluid
por: Boman, Andrea, et al.
Publicado: (2016)

Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington’s disease
por: Lowe, Alexander J., et al.
Publicado: (2020)

Correction: Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis
por: Orlovska-Waast, Sonja, et al.
Publicado: (2019)

Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer’s disease
por: Herden, Janne Marieke, et al.
Publicado: (2023)

Author Correction: Quantifying the relationship between spreading depolarization and perivascular cerebrospinal fluid flow
por: Mukherjee, Saikat, et al.
Publicado: (2023)

Correction: Cerebrospinal Fluid Melanin-Concentrating Hormone (MCH) and Hypocretin-1 (HCRT-1, Orexin-A) in Alzheimer’s Disease
por: Schmidt, Frank M., et al.
Publicado: (2013)

Correction for: YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
por: Andrés‐Benito, Pol, et al.
Publicado: (2021)

Correction to: Mast cell proliferation in the cerebrospinal fluid after intraventricular administration of anti‑B7H3 immunotherapy
por: Kramer, Kim, et al.
Publicado: (2021)

Author Correction: A meta-analysis of the diagnostic utility of biomarkers in cerebrospinal fluid in Parkinson’s disease
por: Xiang, Chunchen, et al.
Publicado: (2023)

Correction: Quantitative Detection of Epstein-Barr Virus DNA in Cerebrospinal Fluid and Blood Samples of Patients with Relapsing-Remitting Multiple Sclerosis
Publicado: (2014)

Correction: Clinical Evaluation of a Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Neisseria meningitidis in Cerebrospinal Fluid
Publicado: (2015)

Correction: Soluble Toll-Like Receptors 2 and 4 in Cerebrospinal Fluid of Patients with Acute Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage
por: Sokół, Bartosz, et al.
Publicado: (2016)

Author Correction: Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression
por: Siafarikas, Nikias, et al.
Publicado: (2022)

Correction: Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion
por: Choi, Yeon Ja, et al.
Publicado: (2013)

Correction: Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
Publicado: (2014)

Correction to: Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC
por: Groveman, Bradley R., et al.
Publicado: (2020)

Correction: High Resolution Crystal Structure of Human β-Glucuronidase Reveals Structural Basis of Lysosome Targeting
por: Hassan, Md. Imtaiyaz, et al.
Publicado: (2015)

Correction: Keratinocyte differentiation promotes ER stress-dependent lysosome biogenesis
por: Mahanty, Sarmistha, et al.
Publicado: (2019)

Correction: Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme
por: Hemmert, Andrew C., et al.
Publicado: (2012)

Confounding Factors Influencing Amyloid Beta Concentration in Cerebrospinal Fluid
por: Bjerke, Maria, et al.
Publicado: (2010)

Correction: Loss of β-Glucocerebrosidase Activity Does Not Affect Alpha-Synuclein Levels or Lysosomal Function in Neuronal Cells
por: Dermentzaki, Georgia, et al.
Publicado: (2021)

Author Correction: A Genetic Screen for Investigating the Human Lysosomal CystineTransporter, Cystinosin
por: Deshpande, Anup Arunrao, et al.
Publicado: (2019)

Correction: TXNIP mediates high glucose-induced mitophagic flux and lysosome enlargement in human retinal pigment epithelial cells
por: Devi, Takhellambam S., et al.
Publicado: (2022)

Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells
por: Circu, Magdalena, et al.
Publicado: (2018)

The Influence of Blood Contamination on Cerebrospinal Fluid Diagnostics
por: Schwenkenbecher, Philipp, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cdm7pdstr62bsnmdhu7obf4j99